Satoru Iwasa
Expertise in
7
conditions

Satoru Iwasa

Tokyo, JP 
Expertise in
7
conditions
Tokyo, JP 

Overview

Satoru Iwasa practices practicing medicine in Tokyo, Japan.

Mr. Iwasa is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Esophageal Cancer, PIK3CA-Related Overgrowth Spectrum, and Colorectal Cancer.

He is actively involved in clinical research, co-authoring 158 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Tokyo, Japan
Other Locations
Department Of Head And Neck, 5-1-1 Tsukiji, Chuo, 1040045, Japan
Niigata, Japan
Kyoto, 1040045, Japan
St. Marianna University, 2-16-1 Sugao, Miyamae Ku, Kawasaki, 2168511, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2026
Intervention Type: Drug
Study Drugs: Tucatinib, Trastuzumab, Fulvestrant
Study Phase: Phase 2
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
Enrollment Status: Active_not_recruiting
Publish Date: June 29, 2026
Intervention Type: Drug
Study Drug: Avelumab
Study Phase: Phase 3
Phase 1, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of DS-1123a in Subjects With Advanced Solid Tumors
Phase 1, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of DS-1123a in Subjects With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: December 24, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

158 Total Publications

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.
PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.
Journal: British journal of cancer
Published: March 14, 2026

Frequently Asked Questions about Satoru Iwasa

Is Satoru Iwasa a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Satoru Iwasa is classified as an Elite expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Satoru Iwasa participate in research or clinical trials?

Yes. Satoru Iwasa has published 158 articles and abstracts on conditions like Stomach Cancer. You can view a list of Satoru Iwasa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Iwasa's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile